Drug Advice by PhoneTELEPRESNCT02889120
Assessment of Drug Prescription by Phone
An observational study of Drug Advice by Phone, run by Centre Hospitalier Universitaire de Besancon.
Trial summary
Prescription of medicines by telephone in French medical call Centres is a part of the general practitioners activity. This study aimed to described drug prescription by phone (MTP) performed in four medical call centers. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Drug Advice by Phone
- How many people
- 1,263 participants
- Where
- No sites listed yet
- Study dates
- Sep 2013to Oct 2013
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: All phone calls, from september to october 2013, leading to a drug prescription by a general practitioner of four medical call centres were eligible.
Who may be able to join
- All phone calls, from september to october 2013, leading to a drug prescription by a general practitioner of four medical call centres..
Who cannot join
- Medical emergency
- Patient refusing or not able to provide consent.
About this study
Official title: Telemedicine Performed by General Practitioners in Medical Call Centres:Quality Assessment of Drug Prescription by Phone
Prescription of medicines by telephone in French medical call Centres is a part of the general practitioners activity.
This study aimed to described drug prescription by phone (MTP) performed in four medical call centers. The primary objective is to evaluate adherence to french practice guidelines for the drug prescription by phone (Haute Autorité de Santé, 2009) The secondary objective is to evaluate the risk/benefit ratio for drug prescription by phone.
- Conditions
- Drug Advice by Phone
- Keywords
- Drug advice by phone, Teleprescription, Medical call centre, Out of hours call
What is being measured
The primary outcome is the main question the study is designed to answer.
Adherence to Practice Guidelines for the drug prescription by phone
The aim is to measure the adherence to HAS (Haute Autorité de Santé, 2009) pratice guidelines for the drug prescription by phone
Measured: 3 days
Risk/benefit ratio for drug prescription by phone
Measured: 3 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Sep 2016 (estimated)
- Study startSep 2013
- Primary completionOct 2013
- Study completionOct 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Drug Advice by PhoneStudies of the same condition, open and under way.
- More trials run by Centre Hospitalier Universitaire de BesanconThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 1,263 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire de Besancon
- Sponsor type
- University, hospital or other
- Collaborators
- Nantes University Hospital, Central Hospital, Nancy, France, Centre Hospitalier Universitaire Dijon
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02889120
- Sponsor's protocol ID
- P/2013/197
- Acronym
- TELEPRES
- Status last verified
- Aug 2016
- First submitted
- 31 Aug 2016
- Last updated
- 5 Sep 2016
- Results posted
- No
- Data monitoring committee
- Yes
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Sep 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Telemedicine Performed by General Practitioners in Medical Call Centres:Quality Assessment of Drug Prescription by Phone
- ClinicalTrials.gov ID
- NCT02889120
- Acronym / sponsor ID
- TELEPRES / P/2013/197
- Conditions
- Drug Advice by Phone
- Keywords
- Drug advice by phone, Teleprescription, Medical call centre, Out of hours call
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,263 participants (actual)
- Lead sponsor
- Centre Hospitalier Universitaire de BesanconUniversity, hospital or other
- Collaborators
- Nantes University Hospital, Central Hospital, Nancy, France, Centre Hospitalier Universitaire Dijon
- Study start
- Sep 2013
- Primary completion
- Oct 2013 (actual)
- Study completion
- Oct 2013 (actual)
- First posted
- 5 Sep 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Prescription of medicines by telephone in French medical call Centres is a part of the general practitioners activity.
This study aimed to described drug prescription by phone (MTP) performed in four medical call centers. The primary objective is to evaluate adherence to french practice guidelines for the drug prescription by phone (Haute Autorité de Santé, 2009) The secondary objective is to evaluate the risk/benefit ratio for drug prescription by phone.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- All phone calls, from september to october 2013, leading to a drug prescription by a general practitioner of four medical call centres were eligible.
Key inclusion criteria (1 listed)
- All phone calls, from september to october 2013, leading to a drug prescription by a general practitioner of four medical call centres..
Key exclusion criteria (2 listed)
- Medical emergency
- Patient refusing or not able to provide consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Adherence to Practice Guidelines for the drug prescription by phone
Time frame: 3 days
The aim is to measure the adherence to HAS (Haute Autorité de Santé, 2009) pratice guidelines for the drug prescription by phone
Risk/benefit ratio for drug prescription by phone
Time frame: 3 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Sep 2016.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Drug Advice by Phone, run by Centre Hospitalier Universitaire de Besancon.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Adherence to Practice Guidelines for the drug prescription by phone (time frame: 3 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Sep 2016.